In COVID-19 patients during admission, increased levels of circulating pro-angiogenic factors such as VEGF-A, PDGF-AA, and PDGF-AB/BB were found in patients with COVID-19 compared to healthy controls, contributing to the vascular remodeling processes and the formation of new blood vessel in COVID-19 [49]. The gene discussed is VEGFA; the disease is COVID-19.